Prescription Freedom Act of 2022

Bill: 117-hr-6512
Sponsor: full_name: Rep. Biggs, Andy [R-AZ-5]
Introduced: 2022-01-28
Policy area: Health
Subjects: Abortion

Drug safety, medical device, and laboratory regulation

Food and Drug Administration (FDA)

Prescription drugs

State and local government operations
Latest action: action_date: 2022-01-31
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2022-01-28
action_desc: Introduced in House
text: <p><b>Prescription Freedom Act of 2022</b></p> <p>This bill generally eliminates the authority of the Food and Drug Administration (FDA) to require that a drug be dispensed only with a prescription. However, the FDA may continue to require a prescription for any drug intended for terminating a pregnancy.</p>

tv_txt: I 117th CONGRESS 2d Session H. R. 6512 IN THE HOUSE OF REPRESENTATIVES January 28, 2022 Mr. Biggs introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To repeal the authority of the Food and Drug Administration to require that drugs be dispensed only upon prescription, and for other purposes.

1. Short title This Act may be cited as the Prescription Freedom Act of 2022 . 2. Repeal of FDA authority to require prescriptions (a) Repeal Effective as of the date that is 6 months after the date of enactment of this Act, subsection (b) of section 503 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353 ) is repealed. (b) References Beginning on the effective date described in subsection (a), any reference in a Federal statute, regulation, or guidance— (1) to prescribing, a prescription, a prescription drug, or a drug subject to section 503(b) of the Federal Food, Drug, and Cosmetic Act is deemed to be a reference to prescribing, a prescription, or a prescription drug, respectively, under applicable State law; and (2) to any requirement or provision of section 503(b) of the Federal Food, Drug, and Cosmetic Act is deemed to be a reference to the corresponding requirement or provision, if any, in applicable State law, as determined by the Federal official or officials responsible for administering the respective Federal statute, regulation, or guidance. (c) Exception Notwithstanding subsections (a) and (b), the Secretary of Health and Human Services may continue to exercise the authority vested by subsection (b) of section 503 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353 ), as in effect on the day before the effective date described in subsection (a), with respect to any drug that is intended for use in terminating a pregnancy.